Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K
Retrovirology 2007, 4:61
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC, Strebel K
Retrovirology 2009, 6:99 (3 November 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Research    
Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
Friew YN, Boyko V, Hu WS, Pathak VK
Retrovirology 2009, 6:56 (4 June 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Research    
APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication
Li L, Liang D, Li J, Zhao RY
Retrovirology 2008, 5:72 (4 August 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
4.


Commentary    
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
Strebel K, Khan MA
Retrovirology 2008, 5:55 (2 July 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
5.


Review    
HIV-1 Vif, APOBEC, and Intrinsic Immunity
Goila-Gaur R, Strebel K
Retrovirology 2008, 5:51 (24 June 2008)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 4 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.